Chronic kidney disease is a silent condition that affects a significant proportion of the world's population. Currently, it is estimated that between 10% and 15% of the population is affected by this disease, and it is expected to be the fifth leading cause of death globally by 2050. However, the diagnosis Early detection of chronic kidney disease remains a challenge, and this is where a very important marker that often goes unnoticed comes into play: albuminuria.
What is albuminuria and why is it so important?
Albuminuria refers to the presence of albumin in the urine, a protein that, under normal conditions, should not be present in significant amounts. Urine albumin testing is a powerful tool for detecting kidney problems before serious complications develop. Urine albumin levels above 30 mg/g creatinine are considered indicative of albuminuria, which indicates the presence of kidney damage. This marker is not only linked to kidney disease but is also associated with an increased risk of cardiovascular disease.
Albuminuria is a powerful predictor of cardiovascular events such as heart attacks and strokes, and is also an early indicator of the onset of chronic kidney disease. In fact, elevated albumin levels in urine are one of the classic risk factors for cardiovascular disease, making albuminuria an essential tool for predicting both kidney and heart problems.
Why isn't albuminuria measured routinely?
Despite the importance of albuminuria in the diagnosis In the early stages of chronic kidney disease, it is estimated that less than 2% of patients have this marker routinely measured. This is because many physicians do not consider albuminuria a priority in clinical evaluation, which could limit the ability to detect and treat kidney disease in its early stages.
The importance of screening and diagnosis early, precocious, premature
Measuring urine albumin should be standard practice, especially in patients with cardiovascular risk factors, such as those with hypertension, diabetes, or a history of cardiovascular disease. This simple urine test can allow physicians to detect kidney damage before it becomes irreversible and, more importantly, initiate treatment to prevent disease progression.
Early treatment of chronic kidney disease, which may include medications such as ACE inhibitors, ARBs, or SGLT2 inhibitors, has been shown to be effective in reducing mortality and cardiovascular events. These drugs not only help slow the decline of kidney function but can also improve cardiovascular health outcomes.
What can we do to improve?
The main message here is that we should all be aware of the importance of measuring albuminuria, especially in patients with risk factors. It is essential that physicians integrate this test into their consultations and use the results to make informed clinical decisions. diagnosis Early diagnosis is key to offering patients the opportunity to receive treatment that not only improves their kidney health but also minimizes the risk of serious cardiovascular complications.
In summary, albuminuria is an invaluable tool for the early detection of chronic kidney disease and the prevention of cardiovascular events. As a medical community, we must work to integrate this test into routine care and ensure that patients receive the diagnosis and timely treatment.